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M I C R O B I O L O G Y
Conditional expression of PfAP2-G for controlled 
massive sexual conversion in Plasmodium falciparum
Oriol Llorà-Batlle1*, Lucas Michel-Todó1, Kathrin Witmer2, Haruka Toda1,  
Carmen Fernández-Becerra1,3, Jake Baum2, Alfred Cortés1,4†
Malaria transmission requires that some asexual parasites convert into sexual forms termed gametocytes. The 
initial stages of sexual development, including sexually committed schizonts and sexual rings, remain poorly 
characterized, mainly because they are morphologically identical to their asexual counterparts and only a small 
subset of parasites undergo sexual development. Here, we describe a system for controlled sexual conversion in 
the human malaria parasite Plasmodium falciparum, based on conditional expression of the PfAP2-G transcription 
factor. Using this system, ~90 percent of the parasites converted into sexual forms upon induction, enabling the 
characterization of committed and early sexual stages without further purification. We characterized sexually 
committed schizonts and sexual rings at the transcriptomic and phenotypic levels, which revealed down-regulation 
of genes involved in solute transport upon sexual commitment, among other findings. The new inducible lines 
will facilitate the study of early sexual stages at additional levels, including multiomic characterization and drug 
susceptibility assays.
INTRODUCTION
Malaria is a vector-borne disease caused by protozoan parasites 
of the genus Plasmodium. Of the five species that infect humans, 
Plasmodium falciparum is the most lethal. During its ~48-hour in-
traerythrocytic development cycle, the parasite develops through 
the asexual ring, trophozoite, and multinucleated schizont stages. 
Upon egress, up to 32 daughter merozoites are released and invade 
new erythrocytes. The asexual growth of the parasite in the human 
blood is responsible for all malaria symptoms, but asexual stages 
cannot infect anopheline mosquito vectors. Human to vector trans-
mission requires that some parasites differentiate into nonreplicating 
sexual forms termed gametocytes, which develop through the mor-
phologically distinct stages I to V over ~10 days. Immature gameto-
cytes are sequestered in tissues such as the bone marrow until they 
are released back to the peripheral blood circulation as mature 
(stage V) gametocytes that are infectious to mosquitoes (1, 2). Since 
gametocytes are essential for transmission, they are an attractive 
target for intervention in the context of renewed efforts to eliminate 
malaria (3).
The first step for the production of gametocytes is the commit-
ment of a subset of asexual parasites to sexual development (1, 2, 4). 
Commitment, defined as a cell state that irreversibly results in sexual 
conversion at a later point (5), is marked by expression of the mas-
ter regulator PfAP2-G (6–8), a transcription factor of the ApiAp2 
family (9). In asexual parasites, the pfap2-g gene is epigenetically 
silenced by heterochromatin containing the histone mark H3K9me3 
and the heterochromatin protein 1 (HP1) (10–12). Activation of the 
gene, which triggers the sexual development program, requires 
eviction of HP1 by the gametocyte development 1 (GDV1) protein 
(13, 14).
Following commitment, the next step for gametocyte produc-
tion is sexual conversion, marked by the expression of specific pro-
teins absent from any replicating blood stages (5). For many years, 
the prevailing model was that sexually committed parasites must 
undergo an additional round of replication before sexual conver-
sion (4), but recent research in P. falciparum and the murine malaria 
parasite Plasmodium berghei demonstrated that when AP2-G ex-
pression starts early enough in the ring stage, conversion can pro-
ceed directly without additional replication after commitment (5, 15). 
The two alternative sexual differentiation pathways are named next 
cycle conversion (NCC) and same cycle conversion (SCC) (5). The 
first developmental stage upon sexual conversion by either path-
way is the sexual ring, also referred to as sexually or gametocyte- 
committed ring, or gametocyte ring (1, 13, 16–18). Sexual rings 
develop into stage I gametocytes and then follow sexual develop-
ment until they reach maturity (stage V).
In P. falciparum, the proportion of parasites that abandon asexual 
growth and start differentiating into gametocytes, referred to as 
the sexual conversion rate, is typically low (<10%), both under 
culture conditions and in human infections. The level of investment 
into production of sexual forms varies between parasite clones 
and is also affected by the environment: While there is a baseline 
level of spontaneous pfap2-g activation and sexual conversion (6), 
several types of stress, including immune pressure, nutrient limita-
tion, and drug pressure, have been proposed to stimulate conversion 
rates (1, 16). To date, the best established stimulus is depletion of 
the serum lipid lysophosphatidylcholine or choline from the culture 
medium (19).
There are no known differences in morphology or physical 
properties between sexually committed schizonts and their asexual 
counterparts or between sexual and asexual rings. Together with 
low levels of sexual conversion, this limits the ability to study these 
initial stages of sexual development, as it is difficult to obtain suffi-
cient biological material and they cannot be readily separated from 
asexual parasites (1). To overcome this limitation, we generated 
parasite lines in which expression of pfap2-g can be conditionally 
activated to induce massive synchronous sexual conversion. Using 
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these new parasite lines, we obtained highly pure preparations of 
sexually committed parasites and sexual rings that enabled the 
characterization of these largely unexplored parasite stages at mul-
tiple levels.
RESULTS
Conditional activation of pfap2-g leads to massive  
sexual conversion
To conditionally activate pfap2-g expression and trigger sexual con-
version in P. falciparum, we designed a conditional activation con-
struct that was inserted immediately upstream of the pfap2-g coding 
sequence [73 base pairs (bp) upstream of the start codon, i.e., be-
tween the promoter and the coding sequence] using the CRISPR- 
Cas9 system (20). The construct consisted of a strong constitutive 
calmodulin promoter (5′cam), the hdhfr selectable marker (confers 
resistance to the drug WR99210), and a terminator sequence. The 
hdhfr marker and terminator are flanked by loxP sites, such that 
upon recombination between the two loxP sites, the 5′cam promoter 
is adjacent to the pfap2-g coding sequence and is expected to con-
trol its expression. Recombination is mediated by the inducible Cre 
recombinase (DiCre), which is active only upon inducing dimeriza-
tion with rapamycin (Fig. 1A) (21).
We integrated the conditional activation construct in the E5 line, 
a 3D7 subclone with high levels of sexual conversion (6). In this 
parasite line, conversion is stimulated by choline depletion (22). In 
a preliminary set of experiments, the DiCre recombinase was ex-
pressed episomally. Treatment with rapamycin resulted in ~30% 
sexual conversion, whereas gametocytes were never observed in di-
methyl sulfoxide (DMSO)–treated control cultures (fig. S1, A and 
B). To achieve higher conversion rates, we generated a new trans-
genic line in which the DiCre expression cassette was integrated at 
the liver specific protein 1 (lisp1) locus, which is dispensable during 
blood stages (Fig. 1, B and C, and fig. S1C) (23). The parasite line, 
termed E5 gametocyte-inducible line (E5ind), was maintained 
under constant WR99210 pressure to select for parasites that keep 
the edited pfap2-g locus in a transcriptionally active state. Treatment 
with rapamycin resulted in efficient excision of the floxed region, 
with undetectable levels of unedited locus by diagnostic polymerase 
chain reaction (PCR) (Fig. 1C).
To determine the optimal time for induction, we added rapamycin 
to tightly synchronized E5ind cultures at different stages. Induction 
at the late trophozoite stage resulted in maximal sexual conversion 
at the cycle after induction (NCC route of conversion) and maximal 
total amount of gametocytes (fig. S2). Conversion via the SCC route 
was observed when cultures were treated at 0 to 5 hours postinva-
sion (hpi), but it occurred at relatively low levels (<10%) (fig. S2B). 
The low levels of conversion by the SCC route were expected from 
the kinetics of DiCre activity, as excision in 50% of the parasites 
requires >10 hours (24). Thus, in the majority of parasites, direct 
conversion via the SCC route is no longer possible by the time re-
combination occurs and PfAP2-G is expressed (5).
On the basis of these results, we established a straightforward in-
duction protocol in which rapamycin is added to sorbitol-synchronized 
cultures when the majority of parasites reach the late trophozoite/
early schizont stage (~20 hours after synchronization) (Fig. 2A). 
Using this protocol, we consistently obtained ~90% sexual conver-
sion (e.g., 90% of the rings at the cycle after rapamycin treatment 
developed as gametocytes), as determined by light microscopy anal-






































Fig. 1. Generation of transgenic parasite lines to conditionally activate pfap2-g expression. (A) Overview of the strategy to generate the inducible parasite lines. The 
conditional activation cassette was integrated using CRISPR-Cas9 technology. Arrows indicate the position of the primers used for diagnostic PCR. Scissors indicate the 
position targeted by the guide RNA, where Cas9-mediated cleavage is expected. HR refers to homology regions. The part of the pfap2-g upstream region (5′pfap2-g) 
presumably including the promoter of the gene remains intact after editing. (B) Schematic of the strategy to integrate the DiCre expression cassette in the lisp1 locus 
using CRISPR-Cas9 technology. (C) Diagnostic PCR analysis to validate the integration of the constructs and to assess recombination in samples collected 24 hours after 
induction with rapamycin and in DMSO-treated controls. WT, wild type.
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Fig. 2. Sexual conversion upon conditional activation of pfap2-g. (A) Schematic of the procedure used to induce pfap2-g expression and trigger sexual conversion in 
the inducible lines. GlcNAc, N-acetylglucosamine. (B) Representative images of Giemsa-stained smears of the gametocytes obtained after induction and quantification of 
sexual conversion rates based on analysis of Giemsa-stained smears (day 5 gametocytes). Data are presented as the average and SEM of six (E5ind) or five (1.2Bind) inde-
pendent experiments. Scale bar, 10 m. (C) Representative Pfs16 IFA images and quantification of the percentage of Pfs16-positive parasites determined 3 days after 
rapamycin induction, in cultures treated or not with ML10. The bar chart at the right shows the distribution of schizonts and mononucleated cells (according to the 
number of nuclei) among Pfs16- negative parasites in ML10-treated cultures. Data are presented as the average and SEM of four (left bar chart) or three (right bar chart) 
independent experiments. In each experiment, >250 parasites were counted. Scale bars, 10 m. (D to F) Transcriptional analysis of pfap2-g, hdhfr, and the endogenous cam 
24 hours after rapamycin or DMSO (control) treatment and in day 4 or 7 gametocytes. Transcript levels are normalized against ubiquitin-conjugating enzyme (uce). Data are 
presented as the average and SEM of three independent experiments.
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high parasitemia, we obtained gametocytemia levels as high as 12%. 
No gametocytes were observed in DMSO-treated control cultures.
Similar conversion rates were estimated using immunofluores-
cence assays (IFAs) with antibodies against the early gametocyte 
marker Pfs16, which is expressed from stage I of gametocyte devel-
opment onward (5). The proportion of Pfs16-positive cells was de-
termined 3 days after induction, when asexual parasites are at the 
schizont stage and parasites undergoing sexual development are at 
gametocyte stage I and already express Pfs16. In some experiments, 
cultures were treated with the cGMP-dependent protein kinase (PKG) 
inhibitor ML10 to block schizont rupture and reinvasion (25), thus 
preventing amplification of nonconverting parasites. In all cases, 
~90% of parasites were Pfs16 positive in rapamycin-induced E5ind 
cultures, whereas no Pfs16-positive parasites were observed in DMSO- 
treated control cultures (Fig. 2C). The majority of Pfs16-negative 
parasites in ML10-treated induced cultures were mononucleated, sug-
gesting that parasites that failed to convert upon induction were pre-
dominantly dead or growth arrested. Only ~2% of parasites in these 
cultures were at the multinucleated schizont stage, the stage expected 
for healthy replicating parasites 3 days after induction (Fig. 2C).
Conditional activation of pfap2-g rescues gametocyte 
production in a gametocyte nonproducer line
To test the inducible system in a gametocyte nonproducer line, we 
used the 3D7 subclone 1.2B, derived from the 3D7-A stock. In the 
3D7-A line and its subclones, including 1.2B, pfap2-g is expressed at 
very low levels and consequently gametocytes are not produced 
(6, 26). Next-generation sequencing of the 1.2B genome, conducted 
as part of an ongoing comparative chromatin immunoprecipitation 
sequencing (ChIP-seq) study, revealed a nonsense mutation in the 
gdv1 gene that introduces a premature STOP codon (Q578*), re-
sulting in a truncated GDV1 protein lacking the last 21 amino acids. 
The mutation was validated by Sanger sequencing (fig. S3). Given 
that GDV1 is an upstream regulator of pfap2-g activation (14), the 
GDV1 truncation in the 1.2B line likely underlies its inability to 
form gametocytes.
We edited the 1.2B genome in an analogous way as we did with 
the E5 line to generate the 1.2Bind line. Induction with rapamycin 
resulted in ~70% sexual conversion, determined by either light mi-
croscopy or Pfs16 IFA, whereas no gametocytes were observed in 
control cultures (Figs. 1C and 2, A to C). This result shows that the 
conditional pfap2-g activation system can overcome a deficiency in 
a factor operating upstream of pfap2-g, indicating that PfAP2-G ac-
tivation is sufficient to trigger sexual conversion. It also supports 
the idea that GDV1 is needed to reverse the silencing of pfap2-g (14) 
but is dispensable for normal gametocyte development thereafter.
Transcriptional changes at the pfap2-g locus upon induction
Transcriptional analysis of E5ind and 1.2Bind 24 hours after rapa-
mycin treatment revealed activation of pfap2-g expression and loss 
of hdhfr expression, as expected (Fig. 2, D and E). However, pfap2-g 
transcript levels were >25-fold lower than the levels of endogenous 
cam transcripts (Fig. 2F) and rather resembled the pfap2-g levels in 
wild-type parasites (5). Furthermore, pfap2-g transcript levels de-
creased severely in maturing E5ind gametocytes (day 4 or 7 gameto-
cytes), similar to the pfap2-g expression pattern in wild-type parasites 
(5, 27) but in contrast to endogenous cam transcripts (Fig. 2, D 
and F). Three features of the system can nonexclusively explain these 
observations: First, there are important differences between the se-
quence of the 5′cam used here (and widely used in malaria research 
to drive the expression of drug resistance markers) (28) and the en-
dogenous cam upstream region, which can determine different pro-
moter activity. Second, after rapamycin-induced recombination 
pfap2-g expression is under the control of two promoters in tan-
dem, the intact endogenous pfap2-g promoter and the 5′cam pro-
moter. Although the 5′cam promoter is located in a more proximal 
position (Fig. 1A), the distal pfap2-g promoter and the associated 
PfAP2-G autoregulatory positive feedback loop (6, 7, 29) may also 
contribute to determining pfap2-g expression. Transcripts contain-
ing sequences of the proximal part of the pfap2-g promoter or the 
5′cam promoter occurred at similarly high levels (comparable to 
endogenous cam transcript levels), which may either reflect tran-
scription from the pfap2-g promoter or the bidirectional activity of 
the 5′cam promoter (fig. S4A) (28). However, transcripts containing 
the pfap2-g coding sequence were far less abundant than transcripts 
containing promoter sequences, revealing a complex landscape 
suggestive of an important role for posttranscriptional mechanisms, 
or truncation of transcription immediately after the loxP site. Third, 
the pfap2-g locus heterochromatin environment may influence the 
activity of the 5′cam promoter. Regardless of the underlying mech-
anism, the roughly physiological pfap2-g transcripts levels and tem-
poral dynamics in the inducible lines are a clear advantage of our 
system, as it resembles natural sexual conversion more faithfully than 
if the gene was markedly overexpressed.
To further explore the influence of reversible epigenetic states on 
pfap2-g activation, we maintained E5ind and 1.2Bind cultures without 
WR99210 pressure for 5 weeks and then induced conversion with 
rapamycin. In both parasite lines, conversion rates were clearly lower 
than in cultures under constant drug pressure (fig. S4B). Selecting back 
the cultures with WR99210 recovered conversion rates (upon in-
duction) to the original levels (fig. S4C), consistent with conversion 
levels depending on reversible epigenetic states. These results suggest 
that in the absence of selection, heterochromatin restricts transcrip-
tion at the pfap2-g locus, even after rapamycin-induced recombina-
tion. In contrast, drug pressure selects for parasites that have the 
5′cam-hdhfr chimera in an active state, which determines pfap2-g 
expression upon recombination. Heterochromatin expansion and 
influence of the epigenetic state of one gene on its neighbors has 
been previously reported at other P. falciparum loci (30, 31).
The few parasites that continue asexual growth after 
induction have heterochromatin at the endogenous  
pfap2-g promoter
In ~1 week, we could establish stably growing populations from the 
few parasites that did not convert upon induction and continued 
proliferating, which we termed E5ind+Rapa_prol and 1.2Bind+ 
Rapa_prol. Diagnostic PCR analysis of genomic DNAs revealed that 
DiCre-mediated recombination had proceeded correctly in these 
parasites (Fig. 3A). Unexpectedly, new gametocytes were formed at 
each growth cycle in E5ind+Rapa_prol but not in 1.2Bind+Rapa_prol, 
with sexual conversion rates and pfap2-g transcript levels that 
resembled those in the respective wild-type E5 and 1.2B parental 
lines (Fig. 3B). This observation supports the idea that, despite the 
constitutive 5′cam promoter being immediately upstream of the 
pfap2-g coding sequence, the probability of pfap2-g activation is af-
fected by the heterochromatin environment at the pfap2-g locus.
To further investigate this possibility, we performed H3K9me3 
ChIP-seq analysis to characterize the distribution of heterochromatin 
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in the E5ind+Rapa_prol and 1.2Bind+Rapa_prol lines and also in 
the E5ind and 1.2Bind lines before rapamycin induction. While in 
wild-type asexual parasites heterochromatin spans the full coding 
sequence and about 3.5 kb of the upstream region (32), in the non-
induced E5ind and 1.2Bind lines, H3K9me3 was present at the 
pfap2-g coding sequence but almost absent from the endogenous 
pfap2-g upstream region and the inserted construct (Fig. 3C). However, 
in parasites that failed to convert into gametocytes upon rapamycin- 
induced recombination (E5ind+Rapa_prol and 1.2Bind+Rapa_prol 
lines), both the endogenous pfap2-g upstream region and coding 
sequence were heterochromatic and only the 5′cam sequence was 
devoid of H3K9me3 (Fig. 3D). This result indicates that when E5ind 
and 1.2Bind cultures are maintained under WR99210 pressure, in 
the majority of parasites, the endogenous pfap2-g promoter remains 
in a euchromatic state that enables them to readily express pfap2-g 
and convert into gametocytes upon rapamycin-induced recombi-
nation. In a small subpopulation of parasites, which was larger in 
1.2Bind (Fig. 3C), this promoter is in a heterochromatic conforma-
tion that prevents expression of pfap2-g even after recombination 
places the 5′cam promoter adjacent to the gene. Since these para-
sites continue proliferating, they are selected when the culture is 
maintained for several days after induction and exhibit a sexual 
conversion rate that likely depends on GDV1-mediated disruption 
of heterochromatin at the pfap2-g promoter (not occurring in 1.2B 
because GDV1 is truncated).
Characterization of mature-induced gametocytes
Both E5ind and 1.2Bind produced male and female mature gameto-
cytes, with apparently normal morphology and at similar rates to the 

































































































Fig. 3. Characterization of parasites that continue asexual growth after rapamycin-induced recombination. (A) Diagnostic PCR to assess recombination at the 
pfap2-g locus in parasites that continue proliferating after rapamycin induction. Genomic DNA was extracted 2 to 3 weeks after induction. (B) Sexual conversion rates (left) 
and analysis of pfap2-g relative transcript levels (right) in parasites that continue proliferating after rapamycin induction, determined 2 to 3 weeks after induction. Tran-
script levels are normalized against ubiquitin-conjugating enzyme (uce). Data are presented as the average and SEM of three biological replicates from independent in-
ductions (except for conversion rates in E5ind+Rapa_prol, N = 5). (C and D) ChIP-Seq profiles of normalized H3K9me3 signal relative to input at the pfap2-g locus. The 
E5ind and 1.2Bind lines were analyzed before induction (C) or in parasites that continue proliferating after induction (D).
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exflagellation of mature male gametocytes and consequently se-
verely reduced ookinete formation, neither inducible line produced 
oocysts upon mosquito infection (Fig. 4, A and B, and fig. S5, E and F). 
The exflagellation defect in E5ind is not attributable to the condi-
tional activation system, as the parental E5 line also failed to exflagel-
late (fig. S5G). IFA analysis during gametocyte activation suggests 
that deficient DNA replication underlies the failure of E5ind and 
1.2Bind male gametocytes to exflagellate and infect mosquitoes 
(Fig. 4, C and D, and fig. S5H). The specific molecular defect in the 
E5 and 1.2B linages has not been identified. While this defect does 
not prevent gametocyte development or activation (including roundup 
and egress), it remains formally possible that it results in currently 
unknown alterations at stages preceding gamete formation.
Transcriptomic profiling of sexually committed schizonts 
and sexual rings
Our inducible sexual conversion system yields high amounts of 
synchronous parasites at the initial stages of sexual development, 
with a level of purity that was not achieved by previous approaches. 
This provides a unique opportunity to describe the largely unchar-
acterized sexually committed schizont and sexual ring stages. Here, 
we characterized the initial transcriptional changes upon pfap2-g 
activation using time course genome-wide transcriptomic analysis.
Overall, we identified 379 genes with altered expression between 
rapamycin-treated and control E5ind cultures [log2(fold change) of 
>1 in two independent biological replicates], of which 77 showed a 
log2(fold change) of >3 (Fig. 5, A and B, fig. S6A, and data file S1). 
Gene families such as surfin or etramp were enriched in up-regulated 
genes, whereas large families involved in antigenic variation were 
generally enriched in down-regulated genes (fig. S6B and data file 
S2). The majority of transcriptional differences were observed at the 
latest time point analyzed, which corresponds to the late sexual ring 
stage (~15 to 20 hpi of the cycle after induction) (Fig. 5C). At the 
early sexual ring stage (~5 to 10 hpi), the most up-regulated gene 
was the early sexual marker gexp02 (Fig. 5, A and B) (22). Genes 
highly up-regulated upon pfap2-g activation included well-established 
early gametocyte markers such as pfs16, pfg27/25, and pfg14-744 
and many genes up-regulated early during P. falciparum sexual de-
velopment identified by recent genome-wide studies (Fig. 5A) 
(6, 7, 10, 14, 17, 19, 33, 34). Many of the most up-regulated genes 
(71% of genes with log2[fold increase] >3) were bound by PfAP2-G 
according to a recent ChIP-seq study (Fig. 5A) (29), whereas only 
7% of the rest of genes in the genome were bound (P = 2.2 × 10−16 
using Fisher’s exact test). This result indicates that the majority of 
highly up-regulated genes are direct targets of PfAP2-G. In con-
trast, very few of the genes down-regulated upon pfap2-g activation 
are bound by PfAP2-G (5% of genes with a log2[fold-decrease] >3) 
or had been reported to change during sexual development (Fig. 5A). 
Down-regulated genes included genes with known functions asso-
ciated with asexual development, such as mesa, hrpIII, pfemp3, pf332, 
and kahrp, and revealed many potential previously unidentified asexual 
parasite markers. The high level of purity of our sexual and control 
preparations (~90% sexual and 100% asexual, respectively) enables 
the identification of genes down-regulated during sexual commitment 
and development. This was not possible using previous approaches 
in which many asexual parasites were still present in the preparations 
enriched in sexual parasites. Only a study using fluorescence-activated 






























































Fig. 4. Characterization of E5ind and 1.2Bind mature gametocytes. (A) Exflagellation rate (percentage of exflagellation normalized by gametocytemia) of mature 
gametocytes of the different parasite lines. Data are presented as the average and SEM of five to seven independent experiments. (B) Number of oocysts per mosquito 
midgut 9 days after blood feeding. Data are presented as average and SEM of the pooled values from three independent feeding experiments (E5, 117 midguts; 1.2B, 155 
midguts; NF54, 137 midguts). (C) Distribution of male gamete types 25 min after activation. Male gametes were classified into four categories after IFA with anti–-tubulin 
(stains microtubules, including the flagella) and anti–glycophorin A (an erythrocyte membrane marker) antibodies and 4′,6-diamidino-2-phenylindole (DAPI) staining of 
nuclei. Replication defect: Parasites that rounded up but had not replicated the genome (single nucleus). Delayed egress: Parasites that replicated the genome and 
formed axonemes but were still inside the red blood cells. Others: Other defects such as parasites lacking properly formed axonemes. Exflagellating: Parasites that devel-
oped correctly. Data are presented as the average and SEM of three or four independent experiments (E5ind, 389 male gametes; 1.2Bind, 769 male gametes; NF54, 
406 male gametes). (D) Representative images of the categories described in (C). Scale bars, 10 m.
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Fig. 5. Transcriptomic analysis of the alterations that ensue upon pfap2-g activation. (A) Expression profile of genes with a log2 of the expression fold change (FC) 
between induced and control cultures of >3 in two independent biological replicates (at any of the time points analyzed). Values are the average of the log2(FC) in the 
two replicates. Genes are ordered by FC value. Samples were collected at 40 to 45 hpi of the cycle of induction or ~5 to 10 and ~15 to 20 hpi of the next cycle. PlasmoDB 
IDs are provided for genes that do not have a unique annotation. Genes that were identified as gametocyte markers in an integrative analysis (purple), direct targets of 
PfAP2-G as determined by ChIP-seq (orange), and genes up-regulated (dark blue) or down-regulated (light blue) in gametocytes in previous studies are indicated. (B) Time 
course relative expression levels (normalized log2 ratio of Cy5-labeled samples signal versus Cy3-labeled reference pool signal) of selected genes in DMSO (control) and 
rapamycin-treated cultures. The dotted lines indicate the time of schizont rupture and reinvasion. (C) Venn diagram showing the number of genes with altered expression 
at each time point [log2(FC) > 1]. (D) Expression FC only for genes showing a log2(FC) > 1 at 40 to 45 hpi.
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fraction of the most down-regulated genes in our analysis, which 
are genes that show decreased expression at the late sexual ring 
stage (Fig. 5A).
Next, we focused specifically on genes showing altered expression 
at the committed schizont stage (40 to 45 hpi of the induction 
cycle). Thirty-six genes were up-regulated in committed versus non-
committed schizonts (log2 [fold-change] >1 in two biological repli-
cates), including several previously reported commitment markers 
and PfAP2-G targets, whereas only six genes were down-regulated 
in addition to the hdhfr marker (Fig. 5, B and D). Of note, three of 
these six genes (clag3.1, clag2, and rhoph3) encode components of 
the RhopH complex, which participates in erythrocyte invasion and 
solute transport (35–37).
A recent report showed that, in sexually committed schizonts, 
PfAP2-G binds the promoter of many invasion-related genes, 
which suggests that it may contribute to their regulation (29). We 
found that the expression of the majority of invasion genes bound 
by PfAP2-G was not altered between induced and control cultures 
(fig. S6C). We identified a very small number of differentially ex-
pressed invasion genes: Excluding pseudogenes, only msrp1 and, to 
a lesser extent, msp11 were up-regulated, whereas only components 
of the RhopH complex were down-regulated. Both up- and down- 
regulated invasion genes and pseudogenes are bound by PfAP2-G 
(fig. S6C), in contrast to genes down-regulated at the sexual ring 
stage that are generally not bound by PfAP2-G (Fig. 5A). Of note, 
the up-regulated pseudogene rh6 is in close proximity to msrp1, 
which is suggestive of regional activation events possibly associated 
with chromosome topology (38).
The RhopH complex and solute transport are  
down-regulated during sexual development
To determine whether the expression of RhopH complex genes is 
reduced in wild-type committed cells, we analyzed their transcript 
levels in the NF54 line under basal conditions (sexual conversion 
rate, ~10%) and after stimulating conversion by choline depletion 
(~50% conversion) (22). Consistent with the results for the E5ind 
line, the expression of clag3.1 and rhoph3 was lower in stimulated 
cultures, whereas rhoph2 and rap1 transcript levels did not change 
(Fig. 6A). The modest magnitude of the differences observed in 
these experiments was expected given that choline-depleted cul-
tures still contain many asexual parasites. Western blot analysis of 
E5ind schizont pellets and culture supernatants with antibodies 
against CLAG3 (cytoadherence linked asexual protein 3) revealed 
a clear reduction in CLAG3 levels in induced compared to control 
cultures (Fig. 6B), confirming that the lower transcript levels in 
committed schizonts translate into lower protein levels.
The RhopH complex is initially expressed in schizonts. After re-
invasion and maturation to the trophozoite stage, it participates in 
the formation of the plasmodial surface anion channel (PSAC) (36), 
which determines the permeability of infected erythrocytes to mul-
tiple solutes, including sorbitol. To determine whether lower ex-
pression of RhopH components in sexually committed schizonts is 
associated with reduced PSAC activity, we performed sorbitol lysis 
experiments with E5ind cultures at the cycle following rapamycin 
induction. A 10-min treatment with 5% sorbitol produced osmotic 
lysis of all mature parasites (trophozoites and schizonts) in control 
E5ind cultures, whereas in induced cultures, the majority of parasites 
(stage I gametocytes) survived. The level of sorbitol survival also 
correlated with the level of sexual conversion in the independent 
parasite line E5-PfAP2-G-DD, which has a destabilization domain 
appended to PfAP2-G to modulate sexual commitment (Fig. 6C) (6). 
These results are consistent with previous reports showing that ga-
metocytes are more resistant to sorbitol lysis than late stage asexual 
parasites (39). We also characterized PSAC function by assessing the 
uptake of 5-aminolevulinic acid (5-ALA), which requires functional 
PSAC (37). As expected, the proportion of parasites incorporating 
the compound was much lower in induced than in control cultures 
(Fig. 6D). Together, these results confirm that the expression of some 
RhopH complex components is reduced in sexually committed 
schizonts, resulting in lower PSAC activity in sexual parasites.
Sexually committed merozoites do not have a preference 
for reticulocyte invasion
The high purity of the E5ind committed schizont preparations en-
ables the phenotypic characterization of parasites at this stage. Dif-
ferential ligand expression in committed schizonts and merozoites 
was previously proposed as a mechanism underlying homing of 
sexual parasites to the bone marrow or enhancing invasion of retic-
ulocytes, which are abundant in this tissue (29, 40). To test whether 
committed merozoites preferentially invade reticulocytes, we com-
pared the relative invasion of reticulocytes and erythrocytes by 
Percoll-purified schizonts from induced and control cultures. As a 
source of reticulocytes and erythrocytes, we used reticulocyte- 
enriched cord blood. Flow cytometry analysis revealed a similar distri-
bution of new rings in reticulocytes (CD71-positive) and erythrocytes 
(CD71-negative) between induced and control cultures (Fig. 6, E 
and F). While we cannot completely exclude the possibility that re-
ticulocytes from other sources may be preferentially invaded by 
sexually committed merozoites, this result suggests that committed 
merozoites do not have a specific tropism for reticulocytes.
DISCUSSION
Investigations of sexually committed schizonts and sexual rings 
have been hampered by the relatively low abundance of these stages 
in mixed cultures and the difficulty in achieving efficient separation 
from their asexual counterparts. Here, we describe a conditional ac-
tivation system for pfap2-g that can be used to induce massive syn-
chronous sexual conversion. The high efficiency of the system, with 
asexually growing parasites almost absent after induction, enables 
the characterization of committed schizonts and early sexual stages 
without any further purification step. We demonstrate the utility of 
the system by providing a detailed characterization of the transcrip-
tome of these stages and showing its suitability for phenotypic char-
acterization. The system can also be used to characterize early sexual 
parasites at any other level (e.g., drug susceptibility screens, nascent 
transcript measurements, and epigenomic, metabolomic, or pro-
teomic analysis). We also used the system to show that pfap2-g acti-
vation is sufficient to trigger productive sexual conversion, even in 
parasite lines with defects in GDV1. The same approach used here 
to generate the E5ind and 1.2Bind lines could be applied in the fu-
ture on the background of a parasite line competent for mosquito 
infection (e.g., NF54). However, while obtaining parasite prepara-
tions highly enriched in the initial stages of sexual development was 
not possible until now, efficient methods to obtain pure prepara-
tions of mature gametocytes in large amounts are already available 
(41, 42). Thus, we consider that our system would have limited util-
ity for the study of mature gametocytes.
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Fig. 6. Functional characterization of sexually committed schizonts and early sexual stages. (A) Expression of RhopH complex genes and rap1 (control) in committed 
schizonts of the NF54 line. Values are the FC between inducing (−choline) and noninducing (+choline) conditions. Transcript levels were normalized against rama. In all 
panels, data are presented as the average and SEM of independent biological replicates. N = 4. (B) Western blot analysis of E5ind culture supernatant or mature schizont 
pellets with antibodies against CLAG3 and the loading controls AMA1 or HSP70. The bar chart shows the fold decrease in normalized band intensity between induced 
and noninduced cultures. N = 3 (supernatant) or 4 (pellet). (C) Sorbitol resistance assay performed ~30 to 40 hpi at the cycle after induction. Values are the percentage of 
pigmented parasites surviving sorbitol treatment. Shield 1 (Shld) stabilizes PfAP2-G in E5-PfAP2-G-DD cultures. N = 3. (D) Uptake of 5-ALA in induced and non-
induced E5ind cultures. Representative fluorescence microscopy images and quantification of the proportion of positive parasites are shown. N = 3. Scale bars, 10 m. (E) Flow 
cytometry analysis of invasion preference by committed and noncommitted merozoites. Reticulocytes were identified by CD71 signal and parasites by Hoechst signal. 
Representative dot plots are shown. PE, phycoerythrin. (F) Distribution of parasites between erythrocytes and reticulocytes after invasion by committed and noncommitted 
merozoites. N = 2.
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Previous systems for inducible sexual conversion in P. falciparum 
achieved sexual conversion rates of 30 to 60% (5, 6, 10, 14, 19), as 
the expression of the master regulator pfap2-g was not directly con-
trolled. With a consistent sexual conversion rate of ~90% in the 
E5ind line and the majority of the remaining ~10% parasites failing 
to develop rather than growing asexually, the system presented here 
stands out as the method that yields highest purity P. falciparum 
early sexual parasite preparations. In induced parasites, the 5′cam 
promoter is adjacent to the pfap2-g coding sequence, resulting in 
activation of the gene in the vast majority of parasites. However, the 
temporal dynamics of expression and transcript levels of pfap2-g 
resemble endogenous pfap2-g expression in wild-type parasites 
rather than expression of the endogenous cam gene. While we were 
unable to fully clarify the underlying mechanism for this unexpected 
observation, physiological pfap2-g expression is a beneficial feature 
of the system that favors the correct formation of gametocytes and 
dispensed the need to screen multiple promoters. Conditional acti-
vation of sexual conversion has also been described in P. berghei. 
Using an approach similar to the one described here, based on con-
ditional activation of ap2-g upon DiCre-mediated promoter flipping, 
conversion of the majority of parasites was achieved (15).
Together with single-cell transcriptomic approaches, purifica-
tion of sexual parasites, and comparative analysis of gametocyte 
producing and nonproducing lines (7, 17, 27, 33, 43, 44), previously 
reported inducible systems were instrumental to gain insight into 
the transcriptome of the initial stages of sexual development. Howev-
er, the high conversion rate obtained with our inducible system pro-
vides important advantages for an accurate transcriptomic profiling 
of these stages. While the majority of genes up-regulated in com-
mitted or early sexual parasites had been previously identified by 
other approaches, the high level of purity of our committed schizont 
and sexual ring preparations also enabled the identification of down- 
regulated genes. In previous studies, down-regulation was probably 
masked by transcripts arising from abundant asexual parasites pres-
ent in the bulk population. Our approach also provides insight into 
the temporal order of events in the sexual commitment regulatory 
cascade: Genes proposed to be altered upstream of PfAP2-G activa-
tion, such as the ISWI and SNF2L helicases or GDV1 (7, 14), were 
not up-regulated upon PfAP2-G activation, supporting the idea that 
they operate upstream of PfAP2-G. Our results also clearly demon-
strate that, while expression of some genes involved in sexual com-
mitment and development may occur independently of PfAP2-G 
(18, 45), activation of this transcription factor is sufficient to drive 
the full process. However, characterization of the transcriptional 
changes occurring immediately upon PfAP2-G activation with high 
temporal resolution was not possible because of the intrinsic time 
required for rapamycin-induced recombination with the DiCre 
system (24).
We show that a relatively small number of genes have altered 
expression at the committed schizont stage, and a broad remodel-
ing of the transcriptome does not occur until the sexual ring stage. 
Very few genes involved in erythrocyte invasion showed altered ex-
pression in sexually committed versus noncommitted schizonts. Apart 
from pseudogenes, msrp1 and genes encoding components of the 
RhopH complex were the only clearly up- and down-regulated 
invasion-related genes, respectively. Up-regulation of msrp1 in com-
mitted schizonts, of still unknown functional significance, has 
been consistently observed in several studies (7, 10, 14, 17, 19, 29, 33). 
In contrast, the down-regulation of genes encoding components of 
the RhopH complex was not previously identified. A previous study 
reported up-regulation of some components of the complex (33). 
While the reasons for the discrepancy are unclear, our observations 
are consistent with the known reduction in PSAC function and sor-
bitol sensitivity of gametocytes (39), which we confirmed. Our re-
sults suggest that committed schizonts express RhopH components 
at reduced levels to adjust the permeability of sexually developing 
parasites upon reinvasion, possibly to adapt to lower nutrient needs 
or to prevent the entry of toxic compounds (46). Of note, genes that 
are up-regulated and genes that are down-regulated in committed 
schizonts (but not at other stages) are bound by PfAP2-G. Interac-
tions between PfAP2-G and another ApiAP2 transcription factor, 
PfAP2-I (47), have been proposed to underlie the regulation of in-
vasion genes in committed schizonts (29). Complex interactions 
between the two factors may determine the transcriptional outcome 
of PfAP2-G binding, ranging from activation for the majority of its 
sexual ring and gametocyte-stage targets to no transcriptional change 
for many invasion-related genes, and even reduced expression for 
genes involved in solute transport such as rhoph3 and clag genes.
The insertion of a constitutive promoter to drive pfap2-g expres-
sion also provided insight into the regulation of pfap2-g itself. In 
cultures maintained in the absence of drug pressure, sexual conver-
sion rates were lower, and this was reverted upon reselection with 
the drug. This is suggestive of reversible heterochromatin expan-
sion from neighbor regions influencing the activation of pfap2-g in 
the inducible system. Furthermore, in uninduced E5ind and 1.2Bind 
cultures under constant WR99210 pressure, heterochromatin is 
present at the pfap2-g coding sequence but not at the promoter, 
roughly matching the heterochromatin distribution in gametocytes 
(32). In these parasites, the gene is readily activated upon rapamycin- 
induced recombination, indicating that heterochromatin at the 
pfap2-g coding sequence is compatible with active expression of the 
gene. In contrast, we found that the few parasites that escaped con-
version after rapamycin-induced recombination had the endogenous 
pfap2-g promoter in a heterochromatic state, which was associated 
with restricted activation of the gene and led to sexual conversion 
rates that reflected those observed in the respective parental lines. 
Together, these observations indicate that, in the inducible lines, the 
constitutive promoter adjacent to the gene, the endogenous promoter 
and the locus chromatin environment all contribute to pfap2-g reg-
ulation. We propose a model for endogenous pfap2-g regulation 
whereby the coding sequence is constitutively heterochromatic at all 
stages of the life cycle, including sexually committed and early sex-
ual stages in which the gene is actively expressed. This may serve as 
a permanent “reservoir” from which heterochromatin spreads to 
the promoter region at stages at which the gene needs to be epige-
netically silenced, including asexual blood stages and mosquito 
stages (32, 48). In this scenario, activation of pfap2-g expression in 
committed parasites requires dismantling heterochromatin only at 
the promoter region.
A possible additional layer of regulation of pfap2-g expression 
in gametocytes of the inducible lines, operating at the posttran-
scriptional level, is transcript stability. Of note, altering the activity 
of the exonuclease PfRNase II resulted in up-regulation of PfAP2-G, 
among other sexual markers (49). This raises the intriguing pos-
sibility that this exonuclease, involved in var gene regulation, 
also regulates pfap2-g expression. In support of this idea, a recent 
transcriptomic time course analysis of gametocyte development 
revealed that the expression of the pfrnase II gene peaks at stage I 
Llorà-Batlle et al., Sci. Adv. 2020; 6 : eaaz5057     10 June 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
11 of 16
of gametocyte development, coinciding with the drop in pfap2-g 
transcripts (27).
In summary, we have developed inducible P. falciparum trans-
genic lines that show the highest level of sexual conversion reported 
so far. Using these lines, we provide new insight into the regulation 
of pfap2-g and the transcriptomic and functional changes that occur 
during the initial steps of sexual development. These inducible lines 
will be instrumental to gain a deeper understanding of the forma-
tion of sexual stages, which is expected to facilitate the design of 
new tools to block malaria transmission.
MATERIALS AND METHODS
Parasite cultures and induction of sexual conversion
The 3D7 subclones E5 (derived from the 3D7-B stock) and 1.2B 
(derived from the 3D7-A stock), the E5-PfAP2-G-DD line, and the 
NF54 line have been previously described and characterized 
(6, 26, 41). Parasites were cultured in B+ erythrocytes at 3% hemato-
crit under standard conditions, with RPMI 1640–based culture me-
dium. For 3D7-derived cultures, we used media supplemented with 
0.5% Albumax II (Invitrogen). NF54 cultures were grown in media 
supplemented with 0.25% Albumax II and 5% human serum (41). 
To produce gametocytes for mosquito infection, a 4% hematocrit 
was used. Cultures were regularly synchronized by sorbitol lysis to 
eliminate late asexual stages (trophozoites and schizonts). For some 
experiments, cultures were tightly synchronized to a 5-hour age 
window by purification of schizont stages using Percoll gradients 
(63% Percoll) followed by sorbitol lysis 5 hours later. The PKG inhib-
itor ML10 was used at a concentration of 80 nM to inhibit merozoite 
egress (25). AquaShield-1 (Cheminpharma) was used at a concen-
tration of 0.5 M to stabilize PfAP2-G in the E5-PfAP2-G-DD line.
To induce sexual conversion, E5ind or 1.2Bind cultures were 
sorbitol-synchronized and, after synchronization, maintained with-
out WR99210 (Jacobus Pharmaceutical Co., USA). Typically at 
~20 hours after synchronization, cultures were treated with 10 nM 
rapamycin (Sigma-Aldrich, R0395) or DMSO solvent (control) for 
1 hour (24), which was followed by one wash with incomplete cul-
ture media (culture media without Albumax II) before placing back 
in culture. After reinvasion, cells were grown in serum-supplemented 
media, as it improved gametocyte development. Sexual conversion 
rates were measured by treating cultures at the ring stage after rein-
vasion (day 0) with 50 mM N-acetylglucosamine (Sigma-Aldrich, 
A3286) for 5 days to eliminate asexual parasites. The sexual conver-
sion rate was calculated as the gametocytemia at day 5 relative to the 
initial rings parasitemia at day 0 (5). Parasitemia and gametocyte-
mia were measured by light microscopy quantification of Giemsa- 
stained smears.
To stimulate sexual conversion in the NF54 line, we used the 
choline depletion method (14, 19). Cultures were regularly main-
tained in RPMI 1640-based culture medium with 0.5% Albumax 
and 2 mM choline (Sigma- Aldrich, C7527), and choline was removed 
at the ring stage to stimulate conversion, as previously described (22).
Plasmids
The pL7-Ind-ap2g plasmid was derived from the pL6-egfp-yfcu 
plasmid (20). The yfcu cassette was removed using restriction sites 
Not I and Sac II. Next, a loxP site was cloned into a BamH I site 
between the 5′cam and the hdhfr gene using two annealed and 
phosphorylated oligonucleotides (p1 and p2) containing the loxP 
sequence. The second loxP site was cloned together with the pfap2-g 
homology region 2 (HR2) between the 3′ hrp2 and HR2. The loxP 
sequence was added to primer p3, which was used together with p4 
to amplify the HR2 (positions −73 to +311 bp relative to the pfap2-g 
start codon). The pfap2-g HR1 (positions −449 to −160 bp) was am-
plified with primers p5 and p6. HR1 and HR2 were cloned into Spe 
I/Afl II and EcoR I/Nco I sites, respectively. Last, to clone the guide, 
the plasmid was digested with BtgZ I, and two annealed oligonucle-
otides (p7 and p8) containing the guide sequence (located at −139 
to −158 bp) were cloned into this site using the In-Fusion HD Cloning 
Kit (Clontech).
Plasmid pHH1-cambsd-DiCre was based on plasmids pHH1_
SERA5del3DC (21) and E140-0 (50). The bsd coding sequence was 
amplified with primers p9 and p10 and cloned into E140-0 using 
BamH I and Xho I restriction sites, replacing the hdhfr coding se-
quence and removing unnecessary plasmid elements. After generat-
ing Afl II and Spe I restriction sites upstream of the bsd cassette with 
a PCR-amplified (primers p11 and p12) fragment of the plasmid 
recloned into Hind III and EcoR I sites, the DiCre cassette obtained 
by Afl II and Spe I digestion of pHH1SERA5del3DC was cloned 
into the new Afl II and Spe I sites.
Plasmid pHHI-DiCre-lisp1, which contains the DiCre expression 
cassette flanked by lisp1 HRs, was derived from pHH1-cambsd-DiCre. 
First, the HR2 (positions +5891 to +6235 bp relative to the lisp1 
start codon) was PCR-amplified using primers p13 and p14 and 
cloned into Spe I and Not I sites in pHHI-cambsd-DiCre. The HR1 
(positions +5169 to +5523 bp) was amplified using primers p15 
and p16 and cloned into an Afl II site using the In-Fusion kit 
system. To generate plasmid pDC2- Cas9-hDHFRyFCU-lisp1, a guide 
covering positions +5526 to +5545 bp from the lisp1 start codon 
was prepared by annealing oligonucleo tides p17 and p18 and cloning 
into a Bbs I site of plasmid pDC2- Cas9-hDHFRyFCU (24) using the 
In-Fusion system.
Guides were designed using the EuPaDGT Web-based tool. PCR 
amplifications from P. falciparum genomic DNA were performed 
using LA Taq DNA Polymerase (Takara). To clone the plasmids, we 
used Escherichia coli DH5 or ultracompetent MAX Efficiency 
DH5 (Invitrogen) for difficult cloning. Oligonucleotides were 
from Integrated DNA Technologies. All primers and oligonucle-
otides are described in table S1.
Generation of transgenic lines
All transfections were performed by electroporation of cultures at 
the ring stage. For the inducible line with episomal expression of 
DiCre, E5 cultures were transfected with 60 g of pUF1-Cas9- 
ydhodh (20) and 12 g of pL7-Ind-ap2g linearized using a Sca I site 
(located in the plasmid backbone). Cultures were permanently 
maintained under 10 nM WR99210 pressure. After confirming that 
the pfap2-g locus was correctly edited, cultures were transfected 
with 100 g of the pHHI-cambsd-DiCre plasmid and selected con-
tinuously with blasticidin S (2.5 g/ml) (Thermo Fisher Scientific, 
R21001). For approaches involving stable integration of the DiCre 
expression cassette, we used a three-plasmid strategy. Sixty micro-
grams of pDC2-Cas9-hDHFRyFCU-lisp1, 12 g of pHHI-DiCre-
lisp1, and 12 g of pL7-Ind-ap2g, the latter two linearized using a 
Sca I site (located in the plasmid backbone), were cotransfected and 
selected with 10 nM WR99210 for 4 days as previously described 
(24). Correct edition of the two loci using this strategy was achieved 
only for the E5 line. For the 1.2B line, we had to use a sequential 
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editing strategy: Cultures were first transfected with 60 g of 
pDC2-Cas9-hDHFRyFCU-lisp1 and 12 g of linearized pHHI- 
DiCre-lisp1 plasmids and selected with 10 nM WR99210 for 4 days. 
After subcloning and treatment with 1 M 5-fluorocytosine (clini-
cal grade Ancotil, Mylan N.V.) for 2 weeks to eliminate parasites 
that maintain episomal copies of the pDC2-Cas9-hDHFRyFCU- 
lisp1 plasmid, a second round of transfection was performed with 
60 g of pUF1-Cas9-ydhodh and 12 g of linearized pL7-Ind-ap2g 
plasmids, followed by continuous selection with 10 nM WR99210.
Diagnostic PCR to assess the correct integration of the trans-
genes was performed using the LA Taq DNA Polymerase (Takara). 
The primers used for diagnostic PCR are described in table S1, and 
their relative positions are shown in Fig. 1.
RNA extraction and transcriptional analysis by reverse 
transcriptase quantitative PCR
For the majority of samples, RNA was extracted using the TRIzol 
method, deoxyribonuclease-treated and purified with a protocol 
optimized for low amounts of RNA (51), and reverse-transcribed 
using the AMV Reverse Transcription Kit (Promega) with a mix-
ture of oligo (dT) and random primers. Transcript abundance was 
measured by real-time quantitative PCR (qPCR) using the standard 
curve method in a 7900HT Fast Real-Time PCR System and the 
Power SYBR Green Master Mix (both from Applied Biosystems). 
For samples from stage V gametocytes, RNA collected in TRIzol 
was extracted with the Direct-zol RNA MiniPrep Kit (Zymo Re-
search), complementary DNA (cDNA) synthesis performed using 
the iScript cDNA Synthesis Kit (Bio-Rad), and qPCR analysis of 
male and female markers (52) was performed using the standard 
curve method in a LightCycler 480 Instrument II (Roche) with 
SsoAdvanced Universal SYBR Green Supermix (Bio-Rad). For the 
standard curve, we used genomic DNA from the same parasite line 
being analyzed. Transcript levels of the ubiquitin-conjugating en-
zyme (uce; ID: PF3D7_0812600), serine-tRNA ligase (serrs; ID: 
PF3D7_0717700), or rhoptry-associated membrane antigen (rama; 
ID: PF3D7_0707300) were used for normalization as indicated. All 
primers used for qPCR analysis are described in table S1. For the 
analysis of pfap2-g transcript levels in Figs. 2 and 3, we used primers 
p23 and p24.
IFAs and analysis of 5-ALA uptake
For the analysis of asexual parasites and immature gametocytes, 
IFA analysis was performed on paraformaldehyde (PFA)–fixed 
smears essentially as described (5). For the analysis of stage V ga-
metocytes or activated gametes, samples were fixed with 4% PFA for 
15 min and incubated overnight on top of glass coverslips previously 
coated with poly-l-lysine (Merck Millipore), followed by permea-
bilization, blocking, and antibody incubations. To identify ookinetes 
in mosquito midguts (24 hours after blood feeding), air-dried blood 
drops from single midguts were PFA-fixed and analyzed by IFA. 
The primary antibodies used were mouse anti-Pfs16 (1:400 to 
1:2000; 32F717:B02, a gift from R. Sauerwein, Radboud University), 
mouse anti–-tubulin (1:700; DM1A; Sigma-Aldrich, T6199), rab-
bit anti–glycophorin A (1:200; EPR8200; Abcam, ab129024), rabbit 
anti-Pfg377 (1:1000; batch 6809; a gift from L. Ranford-Cartwright, 
University of Glasgow), and mouse anti-Pfs25 clone 4B7 (1:3000; 
MRA-315, BEI Resources) conjugated to Cy3 (GE Healthcare) (41). 
The secondary antibodies were goat anti-mouse immunoglobulin G 
(IgG)–Alexa Fluor 488 (1:500 to 1:1000; Thermo Fisher Scientific, 
A11029) and donkey anti-rabbit IgG–Alexa Fluor 594 (1:500; Thermo 
Fisher Scientific, R37119). Preparations were visualized with an 
Olympus IX51 epifluorescence microscope, and images were ac-
quired with an Olympus DP72 camera using cellSens Standard 1.11 
software or, for experiments with gametes, a Nikon Ti-E widefield 
microscope with ×60 to 100 objective lens and captured in 0.3-m 
slice z-stack images, which were converted to maximum intensity 
projections in NIS Elements v4.20. All further image processing was 
performed using ImageJ.
5-ALA uptake was determined as previously described (37, 46). 
Synchronized E5ind cultures were treated with rapamycin or DMSO 
and, after reinvasion, when cultures were at the ring stage, 200 M 
5-ALA (Sigma-Aldrich, A3785) was added. Inside of infected eryth-
rocytes, 5-ALA is converted to fluorescent protoporphyrin IX. Up-
take was determined at ~30 to 40 hpi after staining nuclei with 
Hoechst (2 g/ml) for 10 min at 37°C in an eight-well chamber slide 
for live cell fluorescence microscopy. Images were acquired using 
an Olympus IX51 epifluorescence microscope and analyzed using 
ImageJ.
Chromatin immunoprecipitation sequencing
Chromatin extraction from cultures at the late trophozoite/schizont 
stage was performed as previously described (30), with minor mod-
ifications. Briefly, after the cross-linking and washing steps, the 
MAGnify Chromatin Immunoprecipitation System (Life Technologies) 
was used. Samples were sonicated using an M220 sonicator (Covaris) 
at 10% duty factor, 200 cycles per burst, 140 W of peak incident power 
for 10 min. Immunoprecipitations were performed overnight at 4°C 
with 4 g of chromatin and 8 g of antibodies against H3K9me3 
(Diagenode, C15410193) previously coupled to protein A/G magnetic 
beads provided in the kit. Washing, decross-linking, and elution were 
performed following the MAGnify ChIP System recommendations 
but avoiding high temperatures that may result in denaturation of 
extremely AT-rich intergenic regions: De-crosslinking, proteinase 
K treatment, and elution were performed at 45°C (for 2 hours, over-
night, and 1.5 hours, respectively).
Libraries for Illumina sequencing were prepared from 5 ng of 
immunoprecipitated DNA using a protocol adapted to a genome 
with an extremely high AT richness (53). Briefly, after end repair 
and addition of 3′ A-overhangs, NEBNext Multiplex Oligos for Illu-
mina (NEB, E7335 and E7500) were ligated. Purification steps were 
performed with Agencourt AMPure XP beads (Beckman Coulter). 
Libraries were amplified using the KAPA HiFi PCR Kit (Kapa Bio-
systems) in KAPA HiFi Fidelity Buffer (5×) with the following con-
ditions: 95°C for 3 min, nine cycles at 98°C for 20 s and 62°C for 
2.5 min, and 62°C for 5 min. Amplified libraries were purified using 
0.9× AMPure XP beads to remove adapter dimers. The library size 
was analyzed in a 4200 TapeStation System (Agilent Technologies). 
We obtained 12 to 26 million 125 bp paired-end reads per sample 
using a HiSeq2500 System (Illumina).
Transcriptomic analysis using microarrays
Time course transcriptomic analysis was performed using tightly 
synchronized cultures induced at 25 to 30 hpi. Samples for tran-
scriptomic analysis were collected 15, 28, and 38 hours after induc-
tion (corresponding to 40 to 45 hpi schizonts of the first cycle 
and ~5 to 10 or ~15 to 20 hpi rings of the next cycle, respectively). 
RNA was purified using the TRIzol method, and cDNA was synthe-
sized, purified, and labeled essentially as described (26, 54). Samples 
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were analyzed on two-color long oligonucleotide-based custom 
Agilent microarrays. The microarray design was based on Agilent 
design AMADID #037237 (54), modified by adding new probes for 
genes lacking unique probes and for some noncoding RNAs and 
reporter genes (new designs: AMADID-084561 and AMADID- 085763; 
data file S3). All samples, labeled with Cy5, were hybridized against 
a reference pool labeled with Cy3, consisting of a mixture of cDNA 
from rings, trophozoites, and schizonts of E5 and E5ind in equal 
amounts. Microarray hybridization and image acquisition were 
performed as described using a Microarray Scanner (no. G2505C, 
Agilent Technologies) located in a low ozone hood (54).
Bioinformatic analysis
For the analysis of ChIP-seq data, we first removed repetitive k-mers 
from the reads using BBDuK (v36.99) with parameters ktrim = r, 
k = 22, and mink = 6. After this initial filtering, reads where aligned 
to modified 3D7 reference genomes reflecting the alterations intro-
duced by CRISPR-Cas9 genome editing and rapamycin-induced 
recombination (i.e., integration of the DiCre expression cassette 
into the lisp1 locus, integration of the conditional activation cassette 
upstream of the pfap2-g coding sequence, and recombination be-
tween loxP sites in rapamycin-treated samples). Reads alignment 
was performed using Bowtie (v1.2) with parameters --very-sensitive 
and --local, trimming 4 bp from both the 5′ and 3′ ends and restrict-
ing fragment size to 50 to 200 bp. After aligning, duplicate reads 
where removed using PicardTools MarkDuplicates (v2.9.4). For each 
sample, per-base coverage was calculated using BEDtools (v2.27.1) 
and divided by the number of million reads (RPM). For each base, 
H3K9me3 enrichment was calculated as ChIP (RPM)/input (RPM) 
with a pseudocount of 0.1 to avoid division by 0. Data were visual-
ized using IGV (Integrative Genomics Viewer; v2.4.10).
Initial processing of microarray data, including normalization, 
was performed using Feature Extraction software (Agilent) with de-
fault options. The next steps of the analysis were performed using 
Bioconductor in an R environment (R version 3.5.3). For each indi-
vidual microarray, we calculated Cy3 and Cy5 background signals 
as the median of the 100 lowest signal probes for each channel. 
Probes with both Cy3 and Cy5 signals below three times the array 
background were excluded. Gene level log2(Cy5/Cy3) values and 
statistical estimation of parasite age were computed as described 
(26). Genes with missing values or genes that in all samples had 
expression values within the lowest 20th percentile of intensity (Cy5 
channel) were excluded from downstream analysis, including iden-
tification of differentially expressed genes, because differences in 
genes expressed at near-background levels are of low confidence. 
Heatmaps were generated using TMEV 4.9. Gene set enrichment 
analysis (GSEA) with gene lists corresponding to gene families 
(data file S2) was performed using GSEA preranked.
Western blot
Sample preparation for Western blot analysis was performed essen-
tially as previously described (50). Briefly, Percoll-purified schizonts 
were placed in culture at a 0.3% hematocrit, and, after 13 to 20 hours, 
culture supernatants were harvested and mixed with an equal volume 
of 2× SDS–polyacrylamide gel electrophoresis (PAGE) protein loading 
buffer. Schizont extracts were prepared by resuspending Percoll- 
purified schizonts into 20 pellet volumes of phosphate-buffered sa-
line (PBS) and adding an equal volume of 2× SDS-PAGE protein 
loading buffer. Samples were heated for 5 min at 95°C before storing 
at −80°C. For SDS-PAGE, -mercaptoethanol was added to a 4% 
final concentration, and, after boiling again for 5 min at 95°C, proteins 
were resolved in 4 to 8% SDS-PAGE, transferred to nitrocellulose 
membranes, incubated with antibodies, and washed following stan-
dard procedures. The primary antibodies used were mouse anti- 
CLAG3 polyclonal antibodies (36) at 1:2000 (167#2, recognize both 
CLAG3.1 and CLAG3.2; a gift from S. A. Desai, NIAID- NIH, USA), 
rabbit anti-3D7 AMA1 polyclonal antibodies at 1:2000 (a gift from 
R. F. Anders, La Trobe University, Australia), and rabbit anti-PfHSP70 
polyclonal antibodies at 1:10,000 (StressMarq Biosciences, SPC-186C, 
lot no. 1007). As secondary antibody, we used anti-mouse-horseradish 
peroxidase (HRP) (Sigma-Aldrich, A9044) or anti-rabbit-HRP (Sigma- 
Aldrich, A6154) at 1:5000. HRP signal was detected using the Pierce 
ECL Western Blotting Substrate (Thermo Fisher Scientific), and 
membranes were imaged in a LAS4000 system. Band quantification 
was performed using ImageJ.
Reticulocyte invasion assay
Human cord blood samples were obtained from the Barcelona 
Blood and Tissue Bank (www.bancsang.net/), following approval 
for the protocol and informed consent by the Clinical Research Ethics 
Committee of Vall d’Hebron University Hospital [PR(CS)236/2017]. 
Human reticulocyte preparations were performed as previously de-
scribed (55), with some modifications. Briefly, samples were centri-
fuged at 1000g for 15 min (acceleration = 6, deceleration = 2), and 
plasma was removed. Cell pellets were washed with incomplete cul-
ture media at 500g for 10 min and resuspended at 50% hematocrit 
with incomplete culture media. Five milliliters of resuspended 
blood was carefully loaded on 6 ml of 70% Percoll (GE Healthcare) 
and centrifuged at 1200g for 15 min at 20°C (acceleration = 4, decel-
eration = 0). Reticulocytes concentrated in the Percoll interface 
were collected and washed three times with incomplete culture 
media (centrifugation at 400g for 5 min). To deplete leukocytes, 
reticulocyte-enriched pellets were resuspended to a final volume of 
900 l with incomplete culture media and incubated with 100 l of 
CD45 MicroBeads (Miltenyi Biotec, 130-045-801) for 18 min at 
4°C, mixing every 3 min. The cells were washed with incomplete 
culture media and passed through LS Columns (Miltenyi Biotec, 
130-042-401) placed on a magnetic stand. Eluents, containing 
reticulocyte-enriched fractions, were washed twice with incomplete 
culture media, and reticulocyte enrichment was quantified by incubat-
ing for 15 min at room temperature with anti–CD71–phycoerythrin 
(PE) (Miltenyi Biotec, clone AC102, 130-099-219) at a final dilution 
of 1:400. Reticulocyte quantification was performed using a BD 
LSRFortessa flow cytometer.
E5ind schizonts treated with rapamycin or DMSO were purified 
in 70% Percoll gradients and mixed with reticulocyte-enriched or 
control regular erythrocyte preparations to achieve a ~1% parasitemia. 
After establishing 3% hematocrit cultures, parasites were allowed to 
reinvade overnight and analyzed the following day by flow cyto-
metry. Samples were washed in PBS and incubated for 15 min at 
room temperature with anti–CD71-PE antibodies. After washing 
with PBS, parasite nuclei were stained with Hoechst (2 g/ml) for 
20 min. Samples were washed in PBS again before analysis in a BD 
LSRFortessa Cytometer. A total of 200,000 events were recorded per 
sample. After gating erythrocytes, forward scatter height (FSC-H) 
versus forward scatter area (FSC-A) plots were used to define the 
singlets population. Unstained samples and uninfected erythrocyte 
controls were used to define the thresholds for positivity.
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Gamete activation assays
To evaluate exflagellation, a 30-l sample from day 12 E5ind and 
1.2Bind mature gametocyte cultures was mixed with an equal volume 
of ookinete medium [100 M xanthurenic acid, sodium bicarbon-
ate (2 g/liter), and hypoxanthine (50 mg/liter) in RPMI 1640–Hepes 
(pH 7.4)] with a 1:1500 dilution of anti–Pfs25-Cy3 antibody. As a 
control, we used NF54 mature gametocytes induced as previously 
described (41). Part of the preparation was immediately transferred 
to a hemocytometer and incubated at room temperature. After 
15 min, exflagellation centers and erythrocyte density were counted 
using bright-field microscopy (10× magnification) to calculate the 
percentage of exflagellation (number of exflagellating centers rela-
tive to the number of erythrocytes) (56). To compare exflagellation 
between experiments, we determined exflagellation rates by nor-
malizing the percentage of exflagellation by the gametocytemia.
To determine the number of egressing females, the rest of the 
preparation was incubated overnight at 26°C in the darkness to al-
low for maximal expression of Pfs25 on the macrogamete surface 
(56). Female numbers were counted on FastRead slides (Immune 
Systems) and normalized by gametocytemia. For IFA analysis of ac-
tivated male gametes, 200 l of stage V gametocyte cultures was 
mixed with 200 l of ookinete medium and incubated at room tem-
perature for 25 min before fixing with 4% PFA.
Mosquito infection experiments
E5ind, 1.2Bind, and NF54 mature gametocyte cultures (days 12 to 
16) were provided to 3- to 7-day-old Anopheles stephensi mosquitoes 
that were starved the day before the feed. Cultures for mosquito 
feeding were always manipulated at 37°C to prevent premature ac-
tivation of the gametocytes. Fifty to 150 l of prewarmed fresh human 
erythrocytes was used as a cushion to add 10 to 40 ml of gametocyte 
culture on top. The mixture was centrifuged at 500g for 5 min at 
38°C, the supernatant was removed, and the pellet was mixed with 
an equal volume of prewarmed human serum. Five hundred micro-
liters of the mixture was transferred into three-dimensionally printed 
feeders attached to a 38°C circulating water bath (Grant Instru-
ments) (57), with Parafilm placed at the bottom of the feeders to 
have a thin membrane through which the mosquitoes can feed. 
Mosquitoes were allowed to feed for 20 to 30 min and then main-
tained at 26°C and 80% humidity. Twenty-four hours after feeding, 
unfed mosquitoes were removed. To determine the presence of 
ookinetes, mosquitoes were dissected to obtain the midguts (also 
24 hours after feeding), the blood bolus was smeared onto a glass 
slide and fixed with 4% PFA, and ookinetes/females were detected 
using the Pfs25 antibody. Nine days after the feed, mosquito mid-
guts were stained in 0.1% mercurochrome in PBS for 15 min, fixed 
in 4% PFA, and stained with 4′,6-diamidino-2-phenylindole (DAPI). 
Infection intensity was assessed by counting the number of oocysts 
per midgut with a 20× objective.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/24/eaaz5057/DC1
View/request a protocol for this paper from Bio-protocol.
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